FDA Division of Antiviral Drugs director search
Executive Summary
Is at the "short list" stage. At the June 12 meeting of FDA's Antiviral Drugs Advisory Committee, Center for Drug Evaluation and Research Director Carl Peck, MD, announced that he has "a short list of a number of very capable and able candidates." He added: "The interview process has begun [and] we are hoping and expecting to conclude the interview process and the [selection] process by the mid to late part of the summer".